Published in J Electrocardiol on September 25, 2008
Mechanisms of drug-induced proarrhythmia in clinical practice. World J Cardiol (2013) 0.83
Normal standards for computer-ECG programs for prognostically and diagnostically important ECG variables derived from a large ethnically diverse female cohort: the Women's Health Initiative (WHI). J Electrocardiol (2013) 0.81
The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach. Psychopharmacology (Berl) (2015) 0.81
Short-term repeatability of electrocardiographic Tpeak-Tend and QT intervals. J Electrocardiol (2014) 0.79
Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2. BMC Med Genet (2014) 0.76
Electrocardiographic Predictors of Cardiovascular Mortality. Dis Markers (2015) 0.76
QT dynamics during treatment with sertindole. Ther Adv Psychopharmacol (2015) 0.76
The relation between QT interval and T-wave variables in hypertensive patients. J Pharm Bioallied Sci (2011) 0.76
The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat (2009) 2.54
Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol (2002) 2.44
Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol (2008) 2.42
Superior transseptal approach to mitral valve is associated with a higher need for pacemaker implantation than the left atrial approach. Ann Thorac Surg (2007) 2.42
Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J (2004) 2.01
[Prenatal diagnosis of Down syndrome in Denmark 1980-1998 and future progress perspectives]. Ugeskr Laeger (2002) 1.97
Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet (2012) 1.89
Using preventive home monitoring to reduce hospital admission rates and reduce costs: a case study of telehealth among chronic obstructive pulmonary disease patients. J Telemed Telecare (2012) 1.83
Autonomic alterations and cardiac changes in epilepsy. Epilepsia (2010) 1.83
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J (2008) 1.76
Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. Eur J Heart Fail (2010) 1.69
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest (2008) 1.69
Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J (2006) 1.63
Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Cardiovasc Res (2003) 1.61
Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol (2002) 1.61
Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology. Drug Saf (2009) 1.58
Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J (2005) 1.58
High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. Europace (2012) 1.53
Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation (2008) 1.51
Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation (2012) 1.49
T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome. Heart Rhythm (2004) 1.46
Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A. Circ J (2014) 1.45
The genetic basis of Brugada syndrome: a mutation update. Hum Mutat (2009) 1.44
The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote. Circ Cardiovasc Genet (2013) 1.44
Long pacing pulses reduce phrenic nerve stimulation in left ventricular pacing. J Cardiovasc Electrophysiol (2014) 1.40
Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome. Clin Chem (2002) 1.40
The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R). Heart Rhythm (2013) 1.40
Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs (2011) 1.39
Risk markers of late high-degree atrioventricular block in patients with left ventricular dysfunction after an acute myocardial infarction: a CARISMA substudy. Europace (2011) 1.39
Mutations in sodium channel β-subunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res (2010) 1.38
Prevention of atrial flutter with cryoablation may be proarrhythmogenic. Ann Thorac Surg (2007) 1.38
The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study. COPD (2008) 1.28
Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm (2008) 1.27
Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum Mutat (2009) 1.26
Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol (2005) 1.26
One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region. Eur J Hum Genet (2005) 1.25
The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol (2009) 1.21
Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet (2009) 1.21
The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis (2005) 1.20
Interrater reliability of diagnostic methods in traditional Indian ayurvedic medicine. Evid Based Complement Alternat Med (2013) 1.17
Reliability studies of diagnostic methods in Indian traditional Ayurveda medicine: An overview. J Ayurveda Integr Med (2013) 1.17
High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet (2012) 1.17
Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency. Eur J Hum Genet (2004) 1.16
The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet (2009) 1.15
Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol (2009) 1.10
Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation. BMC Med Genet (2012) 1.09
Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome. Heart Rhythm (2005) 1.08
J-shaped association between QTc interval duration and the risk of atrial fibrillation: results from the Copenhagen ECG study. J Am Coll Cardiol (2013) 1.08
Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation. Am J Cardiol (2005) 1.06
Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ Cardiovasc Genet (2012) 1.06
The automatic lung parameter estimator (ALPE) system: non-invasive estimation of pulmonary gas exchange parameters in 10-15 minutes. J Clin Monit Comput (2002) 1.06
ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn (2003) 1.04
Risk of atrial fibrillation as a function of the electrocardiographic PR interval: results from the Copenhagen ECG Study. Heart Rhythm (2013) 1.03
Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Am J Cardiol (2010) 1.03
Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J Biol Chem (2002) 1.03
Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J Am Coll Cardiol (2006) 1.02
Apolipoprotein E genotype and cognitive dysfunction after noncardiac surgery. Anesthesiology (2004) 1.01
Non-invasive estimation of shunt and ventilation-perfusion mismatch. Intensive Care Med (2003) 1.01
Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol (2011) 0.99
The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Neurobiol Aging (2008) 0.99
Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: Which circuits to expect in which substrate? Heart Rhythm (2005) 0.99
Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol (2003) 0.97
C-reactive protein is associated with heart rate variability. Ann Noninvasive Electrocardiol (2007) 0.96
Patients' use of self-monitored readings for managing everyday life with COPD: a qualitative study. Telemed J E Health (2013) 0.96
Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation (2004) 0.96
Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma. Int J Cancer (2009) 0.95
Long QT syndrome in South Africa: the results of comprehensive genetic screening. Cardiovasc J Afr (2013) 0.94
Automated time-resolved immunofluorometric assay for Toxoplasma gondii-specific IgM and IgA antibodies: study of more than 130,000 filter-paper blood-spot samples from newborns. Clin Chem (2002) 0.94
Flow cytometric readout based on Mitotracker Red CMXRos staining of live asexual blood stage malarial parasites reliably assesses antibody dependent cellular inhibition. Malar J (2012) 0.94
Reference values of electrocardiogram repolarization variables in a healthy population. J Electrocardiol (2009) 0.94
Fc γ receptor IIIB (FcγRIIIB) polymorphisms are associated with clinical malaria in Ghanaian children. PLoS One (2012) 0.94
Cost-utility analysis of a telerehabilitation program: a case study of COPD patients. Telemed J E Health (2012) 0.93
Therapeutic hypothermia and ventricular fibrillation storm in early repolarization syndrome. Heart Rhythm (2010) 0.93
Closed-loop control of the heart rate by electrical stimulation of the vagus nerve. Med Biol Eng Comput (2006) 0.92
Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: a CARISMA substudy. Eur J Echocardiogr (2010) 0.91
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate. Vaccine (2011) 0.91
New descriptors of T-wave morphology are independent of heart rate. J Electrocardiol (2008) 0.91
Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study. Clin Drug Investig (2012) 0.90
Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention. Am J Cardiol (2012) 0.90